Kaarina Amberla
- Cellular and Molecular Neuroscience top 5%
- Molecular Biology
- Pharmacology top 2%
- Physiology top 5%
- Developmental Neuroscience top 2%
- Co-authors
- Bengt WinbladAgneta NordbergMatti ViitanenLars BäckmanTed EbendalLars‐Olof WahlundHans LundqvistPer Hartvig
- Topics
- Cholinesterase and Neurodegenerative Diseases (7 papers)Alzheimer's disease research and treatments (6 papers)Dementia and Cognitive Impairment Research (5 papers)
In The Last Decade
Kaarina Amberla
21 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 85
- Cellular and Molecular Neuroscience 612
- Molecular Biology 473
- Pharmacology 380
- Physiology 371
- Developmental Neuroscience 220
Countries citing papers authored by Kaarina Amberla
This map shows the geographic impact of Kaarina Amberla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaarina Amberla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaarina Amberla more than expected).
Fields of papers citing papers by Kaarina Amberla
This network shows the impact of papers produced by Kaarina Amberla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaarina Amberla. The network helps show where Kaarina Amberla may publish in the future.
Co-authorship network of co-authors of Kaarina Amberla
This figure shows the co-authorship network connecting the top 25 collaborators of Kaarina Amberla. A scholar is included among the top collaborators of Kaarina Amberla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaarina Amberla. Kaarina Amberla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 16 | |
| 3 | 11 | |
| 4 | 68 | |
| 5 | 60 | |
| 6 | 64 | |
| 7 | 58 | |
| 8 | 50 | |
| 9 | 387 | |
| 10 | 65 | |
| 11 | 21 | |
| 12 | 43 | |
| 13 | 4 | |
| 14 | 1 | |
| 15 | 114 | |
| 16 | 258 | |
| 17 | 104 | |
| 18 | 10 | |
| 19 | 105 | |
| 20 | 46 |
About Kaarina Amberla
Kaarina Amberla is a scholar working on Pharmacology, Sensory Systems and Psychiatry and Mental health, having authored 21 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (7 papers), Alzheimer's disease research and treatments (6 papers) and Dementia and Cognitive Impairment Research (5 papers). The work is most often cited by research in Developmental Neuroscience (220 citations), Cellular and Molecular Neuroscience (612 citations) and Sensory Systems (120 citations). Kaarina Amberla has collaborated with scholars based in Sweden, Finland and Germany. Frequent co-authors include Bengt Winblad, Agneta Nordberg, Matti Viitanen, Lars Bäckman, Ted Ebendal, Lars‐Olof Wahlund, Hans Lundqvist, Per Hartvig, Anders Lilja and Bengt Långström. Their work appears in journals such as Stroke, Neurobiology of Aging and Behavioural Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.